Raloxifene Hydrochloride
Product Images NDC 71335-1663

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71335-1663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Raloxifene Hydrochloride Str)

FDA Label Image

Image (Raloxifene Graph)

This is a report on the mean percentage change from baseline for total hip bone mineral density, taken from two studies referred to as "NA" and "EUs". Data from both placebo and raloxifene subjects over a 24-month period was analyzed using a fast, 10-treatment approach. Additionally, there is mention of another study called INT which involved hysterectomized women and included subjects receiving conjugated estrogens. However, it is not clear what the findings were for this study. A graph is included to depict the total hip bone mineral density mean percentage change from baseline.*

FDA Label Image

Label Image (Lbl713351663)

This is a pharmaceutical product description for Raloxifene 60mg tablets, packaged by a company called Upane Rusck. The tablets are compared to Evista 60mg tablets made by IniaGen Pharmaceuticals. The package contains 60 tablets with an expiration date of MM/YY and an NDC code of 7133516631. The tablets are white, round, and imprinted with "G256." The product should be stored at room temperature between 20°C-25°C (68°F-77°F), and children should not have access to it. The number 082091146242 is likely a product code or batch number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.